11 Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study.

12 Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar.

13 The usefulness of trained field workers in diagnosis of post-kala-Azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of Bihar

14 Insecticide susceptibility status of Phlebotomus argentipes, a vector of visceral leishmaniasis in different foci in three states of India

15 Crystallographic information data of natural occurring zaccariniite (RhNiAs) obtained by means of precession electron diffraction.

16 Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India.

17 Leishmaniasis in Northern Morocco: Predominance of Compared to .

18 In vitro antiprotozoal activity of some medicinal plants against sleeping sickness, Chagas disease and leishmaniasis.

19 A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.

20 Socioeconomic and behavioural risk factors for infection of visceral leishmaniasis gedaref state – Sudan 2015

21 American cutaneous leishmaniasis in French Guiana: an epidemiological update and study of environmental risk factors.

22 Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

23 Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.

24 Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.

25 Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias

26 Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias

27 Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion

28 Idiopathic interstitial pneumonias medical image detection using deep learning techniques: A survey

29 Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias

30 Transition of concept and treatment for idiopathic interstitial pneumonias

31 Characterization of air flow and lung function in the pulmonary acinus by fluid-structure interaction in idiopathic interstitial pneumonias

32 Do We Need Exercise Tests to Detect Gas Exchange Impairment in Fibrotic Idiopathic Interstitial Pneumonias?

33 The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias

34 Progression of right ventricular dysfunction and predictors of mortality in patients with idiopathic interstitial pneumonias.

35 Disseminated Autochthonous Dermal Leishmaniasis Caused by (PCM2 Trang) in a Patient from Central Thailand Infected with Human Immunodeficiency Virus.

36 A new purified Lawsoniaside remodels amyloid-β fibrillation into a less toxic and non-amyloidogenic pathway.

37 Geobotany of serranías de zapla multiple use ecology reserve: Flora and vegetation

38 Polyphenylsulfone (PPSU) for baby bottles: a comprehensive assessment on polymer-related non-intentionally added substances (NIAS).

39 Prone Regions of Zoonotic Cutaneous Leishmaniasis in Southwest of Iran: Combination of Hierarchical Decision Model (AHP) and GIS.

40 An epidemiological study of visceral leishmaniasis in North East Ethiopia using serological and leishmanin skin tests.

41 Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

42 The adus from the nias collection at the Weltmuseum Wien

43 Trocar Site HERnias After Bariatric Laparoscopic Surgery (HERBALS): a Prospective Cohort Study.

44 High resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis.

45 Publisher Correction: Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition (Nature Communications, (2019), 10, 1, (5273), 10.1038/s41467-019-13356-2)

46 The use of cold atmospheric plasma in pentostam enhancement as Leishmaniasis treatment in vitro

47 Emergence of cutaneous leishmaniasis in a border area at south-east of Iran: an epidemiological survey

48 In the gardens with Ibrahim: An evaluation of fi riyad al-Tafsir by shaykh ibrahim niasse, a contemporary, traditional tafsir

49 Leishmaniasis in cat shelters: A serological, molecular and entomological study.

50 Patients' preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study.

51 Surveillance for Leishmania asymptomatic infection in endemic foci of cutaneous leishmaniasis in Venezuela: a combination of leishmanin skin test and PCR using blood clots improves detection and enables identification of species.

52 Test accuracy of polymerase chain reaction methods against conventional diagnostic techniques for Cutaneous Leishmaniasis (CL) in patients with clinical or epidemiological suspicion of CL: Systematic review and meta-analysis.

53 Leishmania sp. detection and blood-feeding behaviour of Sergentomyia minuta collected in the human leishmaniasis focus of southwestern Madrid, Spain (2012-2017).

54 [Pediatric cutaneous leishmaniasis in Morocco: Clinical and epidemiological features].

55 Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent.

56 [Epidemiology of Cutaneous Leishmaniasis in Algeria through Molecular Characterization].

57 Isolation and Molecular Typing of from in a Re-Emerging Focus of Leishmaniasis, Northeastern Italy.

58 Species diversity and molecular insights into phlebotomine sand flies in Sardinia (Italy)-an endemic region for leishmaniasis.

59 Molecular Analysis of Gene in Non-Healing Clinical Isolates Obtained from Patients with Cutaneous Leishmaniasis from Central of Iran.

60 Geospatial analysis of tegumentary leishmaniasis in Rio de Janeiro state, Brazil from 2000 to 2015: Species typing and flow of travelers and migrants with leishmaniasis.

61 Autochthonous canine visceral leishmaniasis cases occur in Paraná state since 2012: isolation and identification of Leishmania infantum.

62 Serological and molecular investigation of Leishmania spp. infection in cats from an area endemic for canine and human leishmaniasis in Northeast Brazil.

63 Association of Phlebotomus guggisbergi with Leishmania major and Leishmania tropica in a complex transmission setting for cutaneous leishmaniasis in Gilgil, Nakuru county, Kenya.

64 Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients

65 Epidemiology of cutaneous leishmaniasis in Algeria by molecular characterization

66 Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya

67 Molecular epidemiology of human cutaneous leishmaniasis in Jericho and its vicinity in Palestine from 1994 to 2015

68 Molecular epidemiology of imported cases of leishmaniasis in Australia from 2008 to 2014

69 Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran

70 Molecular epidemiology for vector research on leishmaniasis

71 Molecular epidemiology of American tegumentary Leishmaniasis in Panama

72 Molecular epidemiology of leishmaniasis in Asia (focus on cutaneous infections)

73 Antigen genes for molecular epidemiology of leishmaniasis: Polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex

74 The epidemiology of visceral leishmaniasis in East Africa: Hints and molecular revelations

75 Molecular epidemiology of cutaneous Leishmaniasis in Venezuela

76 Leishmania mini-exon genes for molecular epidemiology of leishmaniasis in China and Ecuador

77 International Workshop on Molecular Epidemiology. Proposals of the Interdisciplinary Group on American Trypanosomiasis and Leishmaniasis

78 Molecular approaches applied to the epidemiology of leishmaniasis in Venezuela.

79 Cutaneous Leishmaniasis Due to Leishmania aethiopica

80 Detection of Leishmania spp in silvatic mammals and isolation of Leishmania (Viannia) braziliensis from Rattus rattus in an endemic area for leishmaniasis in Minas Gerais State, Brazil.

81 Zoonotic cutaneous leishmaniasis in Shiraz, Southern Iran: A molecular, isoenzyme and morphologic approach

82 Imported leishmaniasis cases in Cuba (2006–2016): what have we learned

83 Epidemiological Aspects of Visceral Leishmaniasis in Baft District, Kerman Province, Southeast of Iran

84 Old World cutaneous leishmaniasis treatment response varies depending on parasite species, geographical location and development of secondary infection

85 Possible introduction of to urban areas determined by epidemiological and clinical profiles of patients with cutaneous leishmaniasis in Casablanca (Morocco).

86 The enemy at home: leishmaniasis in the Mediterranean basin, Italy on the focus.

87 Characterization of visceral leishmaniasis outbreak, Marsabit County, Kenya, 2014.

88 Changes in the Epidemiology of Cutaneous Leishmaniasis in Northeastern Iran

89 Leishmaniasis in cat shelters: A serological, molecular and entomological study.

90 Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods.

91 A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis.

92 Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis.

93 A cross-sectional approach including dog owner characteristics as predictors of visceral leishmaniasis infection in dogs.

94 The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history.

95 Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis.

96 Expression of a rK39 homologue from an Iranian Leishmania infantum isolate in Leishmania tarentolae for serodiagnosis of visceral leishmaniasis.

97 Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice.

98 Estimation of Biological Parameters of Cutaneous Ulcers Caused by Leishmaniasis in an Animal Model Using Diffuse Reflectance Spectroscopy.

99 Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs.

100 Psychosocial impact of scars due to cutaneous leishmaniasis on high school students in Errachidia province, Morocco

101 Knowledge, attitudes and practices related to visceral leishmaniasis in rural communities of Amhara State: a longitudinal study in northwest Ethiopia.

Keyword Connections

Journals

Research Groups

Bibliographies